Order Article Reprints

Preda A-C, Ciuleanu T-E, Todor N, Vlad C, Iancu DI, Mocan C, Bandi-Vasilica M, Albu F, Todor-Bondei IM, Hapca MC, et al. Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment—The Experience of Ion Chiricuță Oncology Institute. Cancers. 2024; 16(11):2022. https://doi.org/10.3390/cancers16112022

Preda, Alexandra-Cristina, Tudor-Eliade Ciuleanu, Nicolae Todor, Cătălin Vlad, Dana Ioana Iancu, Cristina Mocan, Mariana Bandi-Vasilica, Florina Albu, Irina Mihaela Todor-Bondei, Mădălina Claudia Hapca, and et al. 2024. "Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment—The Experience of Ion Chiricuță Oncology Institute" Cancers 16, no. 11: 2022. https://doi.org/10.3390/cancers16112022

Preda, A.-C., Ciuleanu, T.-E., Todor, N., Vlad, C., Iancu, D. I., Mocan, C., Bandi-Vasilica, M., Albu, F., Todor-Bondei, I. M., Hapca, M. C., Kubelac, M.-P., & Kubelac-Varro, A. D. (2024). Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment—The Experience of Ion Chiricuță Oncology Institute. Cancers, 16(11), 2022. https://doi.org/10.3390/cancers16112022